Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

The Novelty of mRNA Vaccines and Potential Harms: A Scoping Review

Version 1 : Received: 1 January 2023 / Approved: 9 January 2023 / Online: 9 January 2023 (01:54:33 CET)
Version 2 : Received: 11 January 2023 / Approved: 12 January 2023 / Online: 12 January 2023 (03:16:56 CET)

A peer-reviewed article of this Preprint also exists.

Halma, M.T.; Rose, J.; Lawrie, T. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 2023, 6, 220-235. Halma, M.T.; Rose, J.; Lawrie, T. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 2023, 6, 220-235.

Abstract

Pharmacovigilance databases are showing evidence of injury in the context of the COVID-19 modified mRNA shots. According to recent publications, adverse event reports linked to the mRNA COVID-19 products largely point to the spike protein as an aetiological agent of adverse events, but we propose that the platform itself may be culpable. To assess the safety of current and future mRNA vaccines, further analysis on the risks due to the platform itself, and not specifically the expressed antigen. If harm can be exclusively and conclusively attributed to the spike protein, then it is possible that future mRNA vaccines expressing other antigens will be safe. If harms are attributable to the platform itself, then regardless of the toxicity, or lack thereof, of the chosen payload therein, the platform may be inherently unsafe, pending modification. In this work, we examine previous studies of RNA-based delivery by a lipid nanoparticle and break down the possible etiological elements of harm.

Keywords

COVID-19 vaccination; mRNA vaccines; Clinical Trials; Safety Assessment; Novel Technologies; Spike protein

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (2)

Comment 1
Received: 12 January 2023
Commenter: Matthew Halma
Commenter's Conflict of Interests: Author
Comment: We have corrected duplicate text in locations as well as added references for immune-mediated phenomena.
+ Respond to this comment
Comment 2
Received: 17 January 2023
Commenter: John Philip Moore
The commenter has declared there is no conflict of interests.
Comment: Medical and science professionals need to be aware that this preprint is not truly a balanced review of the safety of the Covid-19 mRNA vaccines (or mRNA vaccines in general). What the authors have done is scour the literature for any citation that they can use to cast doubts on mRNA vaccines as a safe and effective platform. It’s cherry-picking combined with speculation. The authors tend to go far beyond what is said in the original publications, to try to make the case that the various components of mRNA vaccines are dangerous. They also ignore the evolution of the technology. Early mRNA vaccine designs tested in animals are not necessarily the same as the more evolved compositions that are now used in humans. The authors try to make the case that the SARS-CoV-2 spike protein is inherently dangerous - a toxin. Here, again, they scour the literature for anything they can use to cast doubts, when there is in fact no proof that spike proteins, in isolation, are inherently dangerous to humans. As a case in point, tens of thousands of humans (including one of the comment writers) have been vaccinated with the Novavax adjuvanted spike protein that is injected directly into muscles (i.e., without expression from an mRNA vector). Other spike protein vaccines have also been tested extensively and successfully in humans. The amount of injected spike protein, delivered as a bolus, greatly exceeds what is expressed over time on the surface of mRNA-transfected cells. And yet no significant safety signals have emerged from the use of these spike protein vaccines.

A balanced review of mRNA vaccines would include all of the dozens of publications on the overall safety of the Covid-19 vaccines both before and above their authorization/approval in multiple countries. This publications invariably show that these Covid-19 mRNA vaccines have an excellent safety profile. Yes, there are legitimate associations between these mRNA vaccines and myocarditis, particularly in young men. These safety signals exist, and are universally acknowledged by medical science. But the side effects are very rare, and are mostly rapidly resolved. In addition, Covid-19 is associated with a much higher prevalence of myocarditis (as well as other health dangers), so the net effect of the mRNA vaccines is to reduce the incidence of such complications. An additional point a balanced review would include is efficacy - the many millions of lives and trillions of dollars the mRNA vaccines have solved worldwide. Accordingly, we encourage readers to take these points into account when reading this article.

We also suggest that readers should do their own due diligence on the qualifications of the authors in relevant areas of medical science, and their membership of groups such as, but not limited to, the World Council for Health. That organization promotes the use of Ivermectin and other questionable and unproven interventions against Covid-19. Some of its members associate with conspiracy theorists such as those who believe Covid-19 is spread by 5G networks and promote an anti-vaccination agenda.

This comment is co-authored by Gregg Gonsalves of Yale University.

Neither co-author has a conflict of interest to declare. We receive no funding or other income from any vaccine company.
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 2
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.